The framework agreement gives eligible healthcare providers, including
Karolinska University Hospital and Region Gotland, access to Omda Cytodose and
related services.
Omda has signed a framework agreement with Region Stockholm for an oncology
treatment management system and related products and services.
The procurement was announced with an estimated framework value of approximately
SEK 65 million. Healthcare organisations eligible to place orders under the
framework include hospitals governed by the Acute Hospitals Committee,
Karolinska University Hospital and Region Gotland.
Karolinska University Hospital has been an Omda customer for more than 15 years,
making the new framework both a renewal and an opportunity to expand this
long-standing relationship. The Karolinska hospital is recognised as one of
Europe's leading cancer hospitals, underlining the demanding clinical
environment Omda's solutions are designed to support.
Omda Cytodose supports mission-critical workflows throughout oncology medication
management, connecting physicians, pharmacists and nurses across prescribing,
preparation and administration. The solution uses clinically validated treatment
protocols and patient parameters to support accuracy, traceability and patient
safety.
"Cancer treatment is one of the most complex and safety-critical areas of
healthcare. Being selected for this framework reflects the confidence placed in
Omda Cytodose and the specialist expertise our team has developed through
decades of close collaboration with healthcare professionals," says Knut Ivar
Rødningen, Business Unit Leader, Medical Oncology at Omda.
The agreement reinforces Omda's position as a leading Nordic provider of
specialised software for oncology medication management. It also marks a shift
from distributor-based sales in Sweden to a direct-sales model, giving Omda a
closer customer relationship and while enhancing business sustainability.
ip and while enhancing business sustainability.\